Frontiers
US$ 20.02
most effective glp-1 clinical trials outcomes trends 2025: real-world data, patient & future therapies most effective glp-1 clinical trials
Description
Research shows a 40-fold increase in these drugs from 2017 to 2021, estimating that roughly 2-3% of the United States is now on either Ozempic or Mounjaro
FDA issued 30 warning letters to telehealth companies for false and misleading claims about compounded GLP-1 products
Doctors warn against the move
The patent on semaglutide, found in Novo Nordisk's Ozempic and Wegovy weight-loss drugs, expired in India on March 20
